Myriad Genetics Inc Cash Flow Quality Index
Myriad Genetics Inc cash flow quality index. Myriad Genetics Inc (MYGN) has a Cash Flow Quality Index of -1.60x as of September 2021. Operating cash flow of $-39.30 Million is below net income of $24.60 Million, suggesting accrual-heavy earnings not yet converted to cash. See Myriad Genetics Inc (MYGN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Myriad Genetics Inc (2008–2020)
Cash flow quality index of Myriad Genetics Inc from 2008 to 2020. Historical Cash Flow Quality Index for Myriad Genetics Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Myriad Genetics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Myriad Genetics Inc Cash Flow Quality Index by Year (2008–2020)
Myriad Genetics Inc cash flow quality index by year from 2008 to 2020. Year-by-year earnings quality comparison for Myriad Genetics Inc. For the full cash flow conversion analysis, see cash flow conversion of Myriad Genetics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 18.20x | $83.70 Million | $4.60 Million | ▲ +0.0% |
| 2019 | 18.20x | $83.70 Million | $4.60 Million | ▲ +1992.7% |
| 2018 | 0.87x | $115.90 Million | $133.30 Million | ▼ -85.8% |
| 2017 | 6.10x | $106.20 Million | $17.40 Million | ▲ +330.1% |
| 2016 | 1.42x | $166.30 Million | $117.20 Million | ▼ -19.0% |
| 2015 | 1.75x | $140.50 Million | $80.20 Million | ▲ +62.3% |
| 2014 | 1.08x | $190.20 Million | $176.20 Million | ▼ -8.6% |
| 2013 | 1.18x | $173.90 Million | $147.20 Million | ▼ -6.6% |
| 2012 | 1.26x | $141.80 Million | $112.15 Million | ▼ -2.7% |
| 2011 | 1.30x | $130.83 Million | $100.71 Million | ▲ +27.6% |
| 2010 | 1.02x | $155.09 Million | $152.30 Million | ▲ +2.5% |
| 2009 | 0.99x | $84.04 Million | $84.61 Million | ▼ -54.2% |
| 2008 | 2.17x | $103.74 Million | $47.84 Million | — |